PHARMACOEPIDEMIOLOGY is still a new word and concept to many pharmacists and physicians. Although Lisi points out that it has been discussed in the literature since 1982,1 and Stewart indicates that research in drug epidemiology dates back to the 1960s,2 it is only now catching the attention of health professionals to the extent that is warranted.
Apparently a third wave of new "pharmaco-" combining forms has begun. The second wave started about 25 years ago with pharmacokinetics and pharmacogenetics. In the third wave, such terms as pharmacoeconomics, pharmacoethics, pharmacogeriatrics, and pharmacoepidemiology are taking on meaning and importance. One pharmaceutical company in an advertisement has even used the word pharmacofinance, which is defined as "money saved on your formulary." Who knows how far this may go, but it is important for responsible educators and practitioners to keep pace with researchers who generate the studies that often make these new words take on significance.
Pharmacoepidemiology is a good example because considerable research in this area is now at the forefront. As our regular readers know, we began an extensive series of articles with our September issue that focuses attention on this important discipline. Pharmacy educators and practitioners need to consider the impact that this discipline will have on them.
Faculty at schools of pharmacy, medicine, and public health should be talking to one another about sharing teaching resources and designing courses for students interested in pharmacoepidemiology. Some curriculum committees may want to consider establishing interdisciplinary courses. I believe that all doctor of pharmacy students should receive some instruction in pharmacoepidemiology. Those students who find the discipline to be particularly interesting should be able to take course work leading to a graduate degree in public health. For example, at one university medical center I recently visited, the school of public health offers the following curriculum leading to an M.P.H. degree in epidemiology:
1. Effects, Risk, and Control, 3 hours; 7. Biostatistical Methods and Data Analysis, 3 hours. These core courses must be taken along with sufficient electives during three semesters to total 36 credit hours. In this illustration about 18 of 36 hours could be used to design an excellent program for the student in pharmacoepidemiology. Faculty should be encouraged in this direction and they, in turn, should stress the importance of this new discipline to selected students.
There will be practitioners who are currently working in the area of drug epidemiology who will want to return to school for postgraduate education in this area. Schools need to prepare themselves for this event.
Hospital pharmacy managers also need to be prepared as it is their departments that should be providing the services that pharmacoepidemiologists render. Pharmacy directors need to educate themselves about the value of these services and then inform their hospital administrators so that steps can be taken to activate a pharmacoepidemiology unit as part of pharmacy services.
